壮骨关节丸

方法：总结1992～1998年中国生物医学文献光盘数据库、北京药品不良反应监察中心和北京地坛医院的壮骨关节丸引起的ADR病例共156例。

Methods : 156 ZW-induced ADR cases in 1992-1998 were collected and reviewed from CBM , Beijing Centre for ADR Monitoring and Beijing Ditan Hospital .

与壮骨关节丸组比较，复方杜仲健骨颗粒组关节功能明显优于壮骨关节丸组。

The result of joint function in compound group was superior remarkably to that of bolus group .

复方杜仲健骨颗粒组总有效率明显优于壮骨关节丸组（92%，82%）。

The total effective rate of compound group was superior remarkably to bolus group ( 92 . % , 82 % ) .

设计：以壮骨关节丸为对照药，双盲双模拟随机方法。

DESIGN : Zhuanggu guanjie wan ( bolus ) was taken as controlled drug and double blind , double-simulation randomized method was designed .

复方杜仲健骨颗粒在改善中医证侯方面优于壮骨关节丸组（积分下降值分别为7.03±3.38,5.43±3.16）。

Concerning to improvement of syndromes in Chinese medicine , the result in compound group was superior to that of bolus group ( the decreased integrals were 7.03 ± 3.38 and 5.43 ± 3.16 respectively ) .

自1999-12/2000-03，进行Ⅲ期临床试验，观察膝关节骨性关节炎患者400例，其中复方杜仲健骨颗粒组300例，壮骨关节丸组100例。

From December 1999 to March 2000 , clinical experiment ⅲ was performed to observe 400 cases of knee joint osteoarthritis , in which , 300 cases were divided in compound group and 100 cases in bolus group .